64 results on '"Grégoire, Marc"'
Search Results
2. KRAS signaling in malignant pleural mesothelioma
3. KRASsignalling in malignant pleural mesothelioma
4. High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma
5. Cross-Species Proteomics Identifies CAPG and SBP1 as Crucial Invasiveness Biomarkers in Rat and Human Malignant Mesothelioma
6. Abstract 319: Impact of chemotherapy on lung cancer cells and their microenvironment, evaluated in tridimensional multicellular tumor spheroids
7. Reply to: Oncolytic Viral Therapy for Malignant Pleural Mesothelioma
8. Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma
9. Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus
10. S100A4 Is a Biomarker of Tumorigenesis, EMT, Invasion, and Colonization of Host Organs in Experimental Malignant Mesothelioma
11. Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma
12. Hybrid Azo-fluorophore Organic Nanoparticles as Emissive Turn-on Probes for Cellular Endocytosis
13. Targeting cell-bound MUC1 on myelomonocytic, monocytic leukemias and phenotypically defined leukemic stem cells with anti-SEA module antibodies
14. Brain-derived neurotrophic factor, a new soluble biomarker for malignant pleural mesothelioma involved in angiogenesis
15. Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
16. Characterization of increasing stages of invasiveness identifies stromal/cancer cell crosstalk in rat models of mesothelioma
17. Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.
18. Viral cancer therapies: are they ready for combination with other immunotherapies?
19. Modulation of the Type I Interferon Response Defines the Sensitivity of Human Melanoma Cells to Oncolytic Measles Virus
20. Evaluation of intracavitary administration of curcumin for the treatment of sarcomatoid mesothelioma
21. Oncolytic measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by human myeloid and plasmacytoid dendritic cells
22. Pleural Effusions from Patients with Mesothelioma Induce Recruitment of Monocytes and Their Differentiation into M2 Macrophages
23. The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27
24. Characterization of preneoplastic and neoplastic rat mesothelial cell lines: the involvement of TETs, DNMTs, and 5-hydroxymethylcytosine
25. Histone Deacetylase Inhibitors Delivery using Nanoparticles with Intrinsic Passive Tumor Targeting Properties for Tumor Therapy
26. Targeting Cell-Bound MUC1 on Myelomonocytic and Monocytic Leukemias and Leukemic Stem Cells: Therapeutic Implications
27. Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response
28. Oncolytic virotherapy for human malignant mesothelioma: recent advances
29. Histone deacetylase inhibitor-polymer conjugate nanoparticles for acid-responsive drug delivery
30. Superacid and thiol-ene reactions for access to psammaplin analogues with HDAC inhibition activities
31. Vorinostat–Polymer Conjugate Nanoparticles for Acid-Responsive Delivery and Passive Tumor Targeting
32. Design of pH responsive clickable prodrugs applied to histone deacetylase inhibitors: A new strategy for anticancer therapy
33. Increased plasmacytoid dendritic cells and RORγt-expressing immune effectors in cutaneous acute graft-versus-host disease
34. Nanoparticles Produced by Ring-Opening Metathesis Polymerization Using Norbornenyl-poly(ethylene oxide) as a Ligand-Free Generic Platform for Highly Selective In Vivo Tumor Targeting
35. Requirement of tumor-associated antigen-specific CD4+ T cells for an efficient dendritic cell vaccine in antitumor immunotherapy
36. Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells
37. Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas
38. MUC1-Specific Cytotoxic T Lymphocytes in Cancer Therapy: Induction and Challenge
39. Impact of HDAC inhibitors on dendritic cell functions
40. Easy and effective method to produce functionalized particles for cellular uptake
41. Purification of circulating plasmacytoid dendritic cells using counterflow centrifugal elutriation and immunomagnetic beads
42. Impact of valproic acid on dendritic cells function
43. Downregulation of MUC1 expression and its recognition by CD8+ T cells on the surface of malignant pleural mesothelioma cells treated with HDACi
44. Human dendritic cells sequentially matured with CD4+ T cells as a secondary signal favor CTL and long-term T memory cell responses
45. Impact of the hypomethylating agent 5-azacytidine on dendritic cells function
46. Vaccination with epigenetically treated mesothelioma cells induces immunisation and blocks tumour growth
47. The effect of perceived intrusion on consumers’ attitude towards using an RFID-based marketing program
48. What's the place of immunotherapy in malignant mesothelioma treatments?
49. Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma
50. Dendritic cell preparation for immunotherapeutic interventions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.